Raymond James & Associates’s Docebo DCBO Stock Holding History

Raymond James & Associates’s Portfolio DCBO Stock Details DCBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,840	Closed	-$476K	–	3948
2023 Q4	$476K	Buy	9,840 +1,282	+15%	+$57.1K	﹤0.01%	2985
2023 Q3	$347K	Sell	8,558 -794	-8%	-$31.4K	﹤0.01%	3109
2023 Q2	$369K	Sell	9,352 -175	-2%	-$6.34K	﹤0.01%	3114
2023 Q1	$388K	Sell	9,527 -89	-0.9%	-$3.27K	﹤0.01%	3067
2022 Q4	$319K	Buy	9,616 +2,190	+29%	+$65.6K	﹤0.01%	3177
2022 Q3	$201K	Sell	7,426 -712	-9%	-$21.7K	﹤0.01%	3440
2022 Q2	$233K	Buy	+8,138	New	+$309K	﹤0.01%	3402
2021 Q3	–	Sell	-6,487	Closed	-$384K	–	4153
2021 Q2	$384K	Buy	+6,487	New	+$332K	﹤0.01%	3260

Other funds holding DCBO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

CRCM

Cat Rock Capital Management Greenwich, Connecticut $644M AUM 1.97% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LPP

Long Path Partners Stamford, Connecticut $220M AUM 25.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Raymond James & Associates's DCBO Position: Q1 2024 in Review

Raymond James & Associates sold out of Docebo (DCBO) in Q1 2024, closing a stake of 9,840 shares — an estimated $476K sold.

Raymond James & Associates first reported a position in DCBO in Q2 2021 and held it in 8 quarters. The position peaked at $476K in Q4 2023. 106 funds tracked by Wall St. Rank hold DCBO as of Q1 2024.

Raymond James & Associates reported no remaining Docebo position as of Q1 2024 after selling out during the quarter.
Raymond James & Associates sold 9,840 Docebo shares in Q1 2024, an estimated $476K.
Raymond James & Associates first reported a position in Docebo in Q2 2021 and held it in 8 quarters.
Raymond James & Associates's Docebo position peaked at $476K in Q4 2023.
106 funds tracked by Wall St. Rank held Docebo as of Q1 2024.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.